Forgot your password?
Sign In
Register

This site allows you to submit a proposal(s) for independent Medical Educational Grants, Sponsorship Requests, Charitable Contributions and/or Donations, and Patient Advocacy Organization Charitable Contributions.


Note, all requests must be submitted at a minimum of 30-days prior to your program start date and it typically takes about 6 to 8 weeks for the BioCryst Grants Review Committee to review requests. Please contact Grants@BioCryst.com if you have a proposal that requires an expedited review process.


When submitting a request, you will be guided through the electronic submission process through instructions and help options. Please make sure that you complete each required field designated by an asterisk (*). Should we need additional information, we will notify you via an email sent to the address you provided upon registration.


We will review all requests. Please note that submission of a request does not indicate that we have agreed to provide support. Support decisions are made only after BioCryst has reviewed your complete request. You will be notified of the decision via an email sent to the address you provided upon registration. All decisions are final.

This site is intended to be used for submitting requests for support of:

  • Medical Educational Requests: Support for independent accredited or unaccredited medical education activities or education directed to healthcare professionals, healthcare organizations, patient organizations, patients, or other members of the healthcare community.


  • Patient Advocacy Organization - Charitable Contributions: Financial or in-kind contributions to patient advocacy groups and organizations with not-for-profit status, where the primary purpose of the contribution is charitable or philanthropic to support the general mission/activities of organizations. Contributions are intended solely for charitable purposes, which means BioCryst receives nothing of value in return other than the customary acknowledgement of support. Unlike for Sponsorship requests, BioCryst does not expect to receive any benefit, consideration, or service in return for Charitable Contributions to patient advocacy organizations.


  • Sponsorships Requests: Funding to an eligible entity including patient advocacy organizations for events or activities in exchange for tangible benefits from the funding recipient, such as the opportunity for BioCryst advertisements at an event or activity, exhibit space at an event, admission to certain events, etc.

  • Charitable Contributions: Donations are tax-deductible contributions to support 501(c)(3) and 501(c)(6) non-profit organizations. The current areas of focus for BioCryst are to promote health-related programs outside of BioCryst therapeutic areas for 501(c)(3) organizations, certain charitable events in support of community health and health education, wellness, scholarships or supporting the education of pharmacy students and to support programmatic activities and scholarships of 501(c)(3) organizations, including hospital foundations.


Our Areas of Interest include:

  • Medical - Hereditary Angioedema (HAE):
    • Defining overall disease burden for patients, families and others impacted by HAE/ bradykinin-mediated angioedema
      • Understanding the impact of HAE disease and unmet needs of underrepresented patient populations
      • Understanding HAE disease and treatment burden on quality of life (including physical and mental health impacts) on patients and caregivers
      • Healthcare utilization costs and financial burden of HAE
      • Evolution of understanding and classification of bradykinin-mediated angioedemas (i.e. HAE normal C1-INH, hereditary, acquired, contact pathway mutations)
    • Redefining HAE/bradykinin-mediated angioedema disease management goals and optimal outcomes
      • Diagnosis, management and outcome measures of success for patients living with HAE/bradykinin-mediated angioedema
      • Review of treatment guidelines/recommendations
      • Individualizing support and shared decision making to improve patient experience and long-term goals for success
        • Options on switching from previous prophylaxis, on-demand treatment, and patient-specific considerations for approved therapies (individualized approach)
      • Diagnosis and management of pediatric patients with HAE/bradykinin-mediated angioedema


  • Patient Advocacy:
    • Local, regional and global patient advocacy focused on:
      • Hereditary Angioedema (HAE)
      • Rare hematological conditions
      • Kidney conditions
      • Vision loss
      • Rare dermatological conditions 
      • Broader rare disease community